Posts Tagged ‘inv:Malaysian-Life-Sciences-Capital-Fund’
Snoqualmie, Wash.-based Light Sciences Oncology, a developer of light-activated cancer drugs, raised $30 million in a second funding round, even though it still has an IPO registration on file with the SEC. The latest funding closes out the company’s second round, which includes a $15 million investment by Fidelity Investments I wrote about here.
The company didn’t name its latest investors in its press release, but according to VentureWire they include Lehman Brothers, the hedge fund Deephaven Capital Management, the Malaysian Life Sciences Capital Fund, and Burrill & Co.
Test line: Technorati Profile
Top Stories
- The Huffington Post confirms $25M third round
- A new, elaborate $20 billion deal for ...
- Mobile ad spending rises as iPhone effect ...
- Joost is loosed on the iPhone. Looks ...
- Breaking: Google News doesn't break tech news
Recent Guest Columnists
- Javier Rojas
The art of the bootstrap - Clifford Reid
The genomic frontier: Personalized medicine in action - Bruce Cleveland
Double down? Spin in? New questions for a new economy
Job Board
- Regional Vice President of Sales
at Marketing Technology Solutions (Jersey City, NJ) - Interactive Production Designer
at EyeWonder, Inc (233 Peachtree Street Atlanta, GA 30303) - Alliance Marketing Consultant BP
at Sun Microsystems (MENLO PARK, CA) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress